Overview

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Status:
RECRUITING
Trial end date:
2028-01-17
Target enrollment:
Participant gender:
Summary
This is a Phase 1 and Phase 2 study to determine the safety profile, RDR and/or MTD, DLT, PK/PD, and preliminary antitumor activity of INV-9956 in adult patients with advanced mCRPC.
Phase:
PHASE1
Details
Lead Sponsor:
Shenzhen Ionova Life Sciences Co., Ltd.